Alaunos Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $109.1M
Liabilities Breakdown FY2019
Total Liabilities: $14.1M
Asset Breakdown
Total Assets: $109.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $79.7M | 73.1% |
| Accounts Receivable | $3.3M | 3.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $24.9M | 22.9% |
Liabilities Breakdown
Total Liabilities: $14.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $906.0K | 6.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $13.2M | 93.6% |